Patient-Centered Practical Vaccine Talk For Busy Clinicians

This study is testing a new educational program called PCP-VAX for primary care providers (PCPs) like doctors and nurse practitioners. The goal is to see if this training helps them have better conversations with adult patients about getting their influenza (flu) and COVID-19 vaccines. Researchers want to find out if this communication training leads to more patients getting vaccinated. The study is looking at vaccine rates for the 2026/2027 flu and COVID-19 seasons. You could be eligible to participate if you are an adult patient of a primary care provider who is part of this study.

Study design: This is an interventional study involving approximately 24,500 participants. It's a pragmatic, cluster randomized trial, meaning groups of clinics will be randomly assigned to either receive the training or not.
What's involved: Not specified in the trial record.
Compensation: Not stated in the trial record.
Follow-up: Researchers will measure vaccine receipt within one month of the end of the study period for both influenza and COVID-19 vaccines.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

Patient-Centered Practical Vaccine Talk For Busy Clinicians

Enrolling by Invitation

NAAges 18+Interventional

University of Massachusetts, Worcester

~24,500 participants

Updated 2026-06-29 on ClinicalTrials.gov

What's tested:Provider communication training

At a glance

Recruiting sites

0 of 1 listed site is recruiting right now

RecruitingSuspended, closed, or not yet open

What they're measuring

Receipt of 2026/2027 influenza vaccine

Measured over Within one month of the end of the study period

+1 more outcome measured

Conditions

Influenza

COVID-19

Where it's being run

1 sites across 1 states

Massachusetts1

Study leadership

Kimberly A Fisher, MD · PRINCIPAL_INVESTIGATOR · University of Massachusetts, Worcester

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime

Eligibility criteria

Inclusion

Practicing primary care provider at study clinic during the study period

Licensed independent practitioner (MD, DO, NP, PA), including residents

Have a qualifying clinic visit, defined as a clinic visit with a study PCP at one of the study clinics during the 2026/2027 influenza vaccine season\*

Have not received the 2026-2027 influenza vaccine prior to the qualifying clinic visit (patients who receive the influenza vaccine on the day of the qualifying study visit are eligible)

Adult (age \>= 18 years)

Have a qualifying clinic visit, defined as a clinic visit with a study PCP at one of the study clinics during the 2026/2027 COVID-19 vaccine season\*

Have not received the 2026-2027 COVID-19 vaccine prior to the qualifying study visit (patients who receive the COVID-19 vaccine on the day of the qualifying study visit are eligible)

Have at least one risk factor for developing severe COVID-19 according to the CDC, including age \>= 65 years

Adult (age \>= 19 years)

Exclusion

PCPs at participating clinic sites who are members of the investigational team or part of the intervention

PCP participants who practice at more than one study clinic that are assigned to discordant study arms (e.g., control and intervention) will be excluded at the outset of the study.

Resident of a state that does not share immunization data with the Massachusetts Immunization Information System (MIIS)

What this trial measures

Receipt of 2026/2027 influenza vaccineWithin one month of the end of the study period
Binary variable, yes/no
Receipt of 2026/2027 COVID-19 vaccineWithin one month of the end of the study period
Binary variable, yes/no

Trialytics